Xanthinol Nicotinate
규격
437-74-1CAS 번호
207-115-7EC 번호
7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione;pyridine-3-carboxylic acidIUPAC 명칭
C19H26N6O6화학식
434.4 g/mol분자량
Xanthinol nicotinate; XANTHINOL NIACINATE; 437-74-1; Sadamine; Nicotinate de xantinol; Nicotinato de xantinol; Xanthinolium nicotinicum; Xantinoli nicotinas; Xantinolo nicotinato; DTXSID0023743; NSC-113217; 8G60H12X2D; DTXCID103743; Complamine; Komplamin; Complamin ret; Niacinate, Xanthinol; Nicotinate, Xantinol; Nicotinate, Xanthinol; RefChem:195114; 207-115-7; Xantinol nicotinate; Complamin; Angioamin; Teonicol; Complamex; Landrina; Stenalgil; Xanidil; Vedrin; Complamin retard; Xavin; Xanthinol niacinate [USAN]; SK 331 A; MFCD00058342; Xantinol nicotinate [INN]; Xanthinol niacinate (USAN); MLS000028609; SK 331A; NSC113217; 7-(2-hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione nicotinate; NCGC00021151-02; Angiomin; Sadamin; SMR000058741; Xanthinolnicotinate; 7-[2-Hydroxy-3-[N-(2-hydroxyethyl)-N-methylamino]propyl]-1,3-dimethylxanthine pyridine-3-carboxylate; Xantinolo nicotinato [DCIT]; 7-{2-Hydroxy-3-((2-hydroxyethyl)methylamino)propyl}theophylline, compound with nicotinic acid (1:1); Xantinoli nicotinas [INN-Latin]; EINECS 207-115-7; Nicotinate de xantinol [INN-French]; Nicotinato de xantinol [INN-Spanish]; NSC 113217; UNII-8G60H12X2D; C19H26N6O6; Complamin (TN); 7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline, compound with nicotinic acid (1:1); 7-{2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl}theophylline, compound with nicotinic acid (1:1); Opera_ID_260; 7-(3-(N-(2-Hydroxyethyl)amino)-2-hydroxypropyl)thiophylline nicotinate; 7- 2-Hydroxy-3-((2-hydroxyethyl)methylamino)propyl theophylline, compound with nicotinic acid (1:1); MLS001148608; MLS001424204; MLS006010909; SCHEMBL121655; orb1219683; orb1305907; CHEMBL1560089; SCHEMBL29422811; XANTHINOL NIACINATE [MI]; GEPMAHVDJHFBJI-UHFFFAOYSA-N; HMS2052E09; HMS2230J12; HMS3371O12; HMS3394E09; HMS5083B18; HY-B1815; XANTINOL NICOTINATE [MART.]; Tox21_110866; EBC-80023; s4868; SBB080746; XANTINOL NICOTINATE [WHO-DD]; AKOS005267237; CCG-101097; CCG-269063; FX00113; NC00347; NCGC00164435-01; 7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethyl-purine-2,6-dione; nicotinic acid; 7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethylpurine-2,6-dione;pyridine-3-carboxylic acid; AS-11613; CAS-437-74-1; DB-051164; CS-0013860; NS00080645; D06334; E75972; SR-01000000242; Q5814478; SR-01000000242-4; (+/-)-7-(2-HYDROXY-3-((2-HYDROXYETHYL)METHYLAMINO)PROPYL)THEOPHYLLINE, COMPOUND WITH NICOTINIC ACID (1:1); {7-[2-Hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]theophylline,} compound with nicotinic acid (1:1); 3-Pyridinecarboxylic acid & {3,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,} 3-dimethyl-1H-purine-2,6-dione (1:1); 3-Pyridinecarboxylic acid,7-dihydro-7-[2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl]-1,3-dimethyl-1H-purine-2,6-dione (1:1); 7-(2-hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione nicotinate; 7-[2-hydroxy-3-[2-hydroxyethyl(methyl)amino]propyl]-1,3-dimethyl-purine-2,6-dione;nicotinic acid; 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione; pyridine-3-carboxylic acid; 7-{2-hydroxy-3-[(2-hydroxyethyl)methylamino]propyl}-1,3-dimethyl-1,3,7-trihydr opurine-2,6-dione, pyridine-3-carboxylic acid; Nicotinic acid compound with 7-(2-hydroxy-3-((2-hydroxyethyl)(methyl)amino)propyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1); pyridine-3-carboxylic acid - 7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1:1); Pyridine-3-carboxylic acid--7-{2-hydroxy-3-[(2-hydroxyethyl)(methyl)amino]propyl}-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (1/1)동의어
